APPLICATION OF WOODLIZUMAB FOR THE TREATMENT OF EOSINOPHIL ASTHMA WITH A DEGREE OF DIFFERENCE TO HEAVY

• 1. PPM1A在哮喘治疗及诊断中的应用 [P] . 中国专利： CN109709326B . 2019.10.01
• 2. PPM1A在哮喘治疗及诊断中的应用 [P] . 中国专利： CN109709326A . 2019-05-03
• 3. APPLICATION OF WOODLIZUMAB FOR THE TREATMENT OF EOSINOPHIL ASTHMA WITH A DEGREE OF DIFFERENCE TO HEAVY [P] . EA201790563A1 . 2017-08-31

  机译： WOODLIZUMAB在严重程度不同的嗜酸性哮喘治疗中的应用

• 4. NOVEL EOSINOPHIL CATIONIC PROTEINS USED IN THE TREATMENT OF ASTHMATIC AND ALLERGIC DISORDERS [P] . 欧洲知识产权局专利： EP1305335A2 . 2003-05-02

  机译： 新型嗜酸性阳离子蛋白用于哮喘和过敏性疾病的治疗

• 5. NOVEL EOSINOPHIL CATIONIC PROTEINS USED IN THE TREATMENT OF ASTHMATIC AND ALLERGIC DISORDERS [P] . 世界知识产权组织专利： WO0185766A3 . 2002-04-18

  机译： 新型嗜酸性阳离子蛋白用于哮喘和过敏性疾病的治疗

• 1. Clinical Study of Acupoint Application of Jiezi Fangxiao Ointment Combined with Pingchuan Prescription in the Treatment of Pediatric Asthma [J] . Yuzhe REN, Zhou YU, Hong CHEN, 药用植物：英文版 . 2021,第002期
• 2. Application analysis of pidotimod in the treatment of allergic rhinitis in children accompanied by allergic asthma [J] . Xia Zhao 海南医科大学学报（英文版） . 2017,第004期
• 3. Application analysis of pidotimod in the treatment of allergic rhinitis in children accompanied by allergic asthma [J] . Xia Zhao 海南医科大学学报(英文版) . 2017,第004期
• 4. Blood Eosinophils, Fraction of Exhaled Nitric Oxide, and Serum Eosinophil Cationic Protein as Surrogate Markers for Sputum Eosinophils in Asthma: Influence of Treatment With Inhaled Corticosteroids [J] . Alvarez Puebla MJ, Aroabarren Aleman E, Corcuera Garcia A, Journal of investigational allergology & clinical immunology: official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunologie . 2018,第3期
• 5. DIFFERENCES IN COMORBIDITIES BY BASELINE EOSINOPHILS FOR PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA FROM THE BENRALIZUMAB SIROCCO AND CALIMA TRIALS [J] . UBALDO MARTIN, J. MARK FITZGERALD, EUGENE BLEECKER, Chest: The Journal of Circulation, Respiration and Related Systems . 2018,第4期
• 6. DIFFERENCES IN COMORBIDITIES BY BASELINE EOSINOPHILS FOR PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA FROM THE BENRALIZUMAB SIROCCO AND CALIMA TRIALS [J] . UBALDO MARTIN, J. MARK FITZGERALD, EUGENE BLEECKER, Chest: The Journal of Circulation, Respiration and Related Systems . 2018,第4期
• 7. Sputum Eosinophil Counts and Eosinophil Cationic Protein (ECP) Levels in Cough-Variant Asthma and in Classic Asthma, and Their Relationships to Airway Hypersensitivity or Maximal Airway Response to Methacholine [C] . Young Yoo, Young Yull Koh, Hee Kang Asia Pacific Congress of Allergology and Clinical Immunology . 2004
• 8. Signaling mechanisms underlying IL-5-family cytokine-induced human eosinophil activation in asthma. [D] . Koziol-White, Cynthia Josephine. 2009
• 9. Asthma Treatment: 194 Influence of Montelukast on the State of Eosinophil Activation in Asthmatic Children [O] . Valéria Botan, Marthina Miranda, Shirley Couto, 2012
• 10. Blood Eosinophils, Fraction of Exhaled Nitric Oxide, and Serum Eosinophil Cationic Protein as Surrogate Markers for Sputum Eosinophils in Asthma: Influence of Treatment With Inhaled Corticosteroids [O] . MJ Alvarez Puebla, E Aroabarren Aleman, A Corcuera Garcia, 2018

• 1. Prevention and Treatment of 88 cases of Asthma with Acupoint Application [J] . ZHANG Shu-yan MA Ze-yun . 中华中医药学刊 . 2007,第3期
• 2. Point Application of Medicated Cakes for Treatment of Asthma in Children——A Report of 60 Cases [J] . 陆力生 ,王明明 ,陈辉丽 . 中医杂志：英文版 . 2006,第3期
• 3. 阳和汤在哮喘治疗中的应用述评 [C] . 李德顺 ,胡作为 ,袁艇 . 中华中医药学会方剂学分会第十二次学术年会 . 2012
• 4. CO2响应性微纳米给药系统的构建及其在哮喘治疗中的应用 [A] . 吴超慧 . 2021